HAE
Haemonetics Corporation
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Haemonetics (HAE) Stock: Buy, Sell, or Hold?
$122.36
+4.15 (+3.51%)
â˛
5d:
+1.73%
30d:
+0.25%
90d:
+33.96%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (44%)
Quality Score
48/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$111.55 â $123.83
Position: SLIGHTLY HIGH
Forward P/E & Valuation
23.1x
STRETCHED
vs 15.2x historical avg
Wall Street Target
$137.50
+12.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$116.68 / $132.00
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: HAE is fairly priced but lacks strong directional signals. At 15.1% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Get Alerted When HAE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$105.09
Based on 5.5% avg growth
INTRINSIC VALUE TODAY
$65.25
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HAE is currently trading at $122.36, which is considered slightly high relative to its 30-day fair value range of $111.55 to $123.83. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.1) compared to its historical average (15.2). At these levels, the market is pricing in 15.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, HAE is in a strong uptrend. Immediate support is located at $116.68, while resistance sits at $132.00. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: HAE scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $137.50 (+12.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HAE is in a strong uptrend. Immediate support is located at $116.68, while resistance sits at $132.00. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: HAE scores 39/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $137.50 (+12.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$111.55 -
$123.83
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.3%
Trading Range & Key Levels
30-Day Trading Range
$111.55 -
$123.83
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$116.68
Resistance Level
$132.00
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (39/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading below Wall St target ($137.50)
- NEUTRAL: Trading at premium valuation - market expects 15.1% growth which is achievable
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
23.12
Wall Street Target
$137.50
(+12.4%)
Revenue Growth (YoY)
9.3%
Earnings Growth (YoY)
23.5%
Profit Margin
7.5%
Valuation Premium vs History
+15.1% premium
PE vs Historical
23.1 vs 15.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+15.1%
(market-implied from PE analysis)
1-Year Target
$140.84
(+15%)
2-Year Target
$162.10
(+33%)
3-Year Target
$186.58
(+53%)
3-Yr Target (if PE normalizes)
(PE: 23â15)
PE COMPRESSION
$122.64
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.1, Growth: 7.0%)
$150.07
(+23%)
Base:
(SPY PE: 19.9, Growth: 7.0%)
$128.89
(+5%)
Bear:
(PE: 15.2, Growth: 7.0%)
$98.64
(-19%)
đ
Valuation based on Current Earnings
Forward PE: 22.78 | Forward EPS (Implied): $5.37
Bull Case
$147.75
(+21%)
Analyst growth 15.0%, PE expands to 23.9
Base Case
$122.36
(0%)
Market implied 0.0%, PE stable at 22.8
Bear Case
$93.61
(-24%)
Severe decline -15.0%, PE contracts to 20.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share HAE Analysis
Share this live HAE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (HAE)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 17, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits is currently flooded with bullish messages for $HAE with no recent news articles to provide additional context.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 10, 2026 9:20 PM ET
Data refreshes hourly during market hours. Next update: 10:20 PM
Data refreshes hourly during market hours. Next update: 10:20 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HAE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 53 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive HAE Research Pages
